Lista de obras -

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

artículo científico publicado en 2009

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

artículo científico publicado en 2002

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

artículo científico publicado en 2016

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

artículo científico publicado en 2008

Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR

artículo científico publicado en 2011

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research

artículo científico publicado en 2012

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

artículo científico publicado en 2013

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia

artículo científico publicado en 2006

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

artículo científico publicado en 2013

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission

artículo científico publicado en 2004

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation

artículo científico publicado en 2008

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

artículo científico publicado en 2003

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

artículo científico publicado en 2018

Comparison of twin and autologous transplants for multiple myeloma

artículo científico publicado en 2008

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

artículo científico publicado en 2012

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

artículo científico publicado en 2014

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission

artículo científico publicado en 2013

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

artículo científico publicado en 2015

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma

artículo científico publicado en 2013

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry

artículo científico publicado en 2002

Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2017

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

artículo científico publicado en 2009

Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma

artículo científico publicado en 2014

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

artículo científico publicado en 2015

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1

scientific article published on 01 September 2019

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

artículo científico publicado en 2017

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

artículo científico publicado en 2008

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma

artículo científico publicado en 2016

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

artículo científico publicado en 2004

New cancers after autotransplantations for multiple myeloma

artículo científico publicado en 2014

Older patients with myeloma derive similar benefit from autologous transplantation.

artículo científico publicado en 2014

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study

artículo científico publicado en 2010

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

artículo científico publicado en 2015

Salvage second hematopoietic cell transplantation in myeloma

artículo científico publicado en 2013

Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia

artículo científico publicado en 2014

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

artículo científico publicado en 2015

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

artículo científico publicado en 2011

Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma

artículo científico publicado en 2013

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

artículo científico publicado en 2009

Lista de obras de

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

Comparison of twin and autologous transplants for multiple myeloma

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry

Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

New cancers after autotransplantations for multiple myeloma

Older patients with myeloma derive similar benefit from autologous transplantation.

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Salvage second hematopoietic cell transplantation in myeloma

Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma